50% more effective than current gold standard

Unmatched cost saving potential

No bleb related complications

A breakthrough in glaucoma implants

Re-defining the

treatment of glaucoma

of the global adult population affected 

2%

of patients will progress to blindness

42%

the direct cost of glaucoma care

$13 B

Awards

Supported by

Featured

Winner

Runner up

Winner

Contact Us

call: +27 (0)21 879 4256

email: daemon@liqidmedical.com